MGC14376 inhibitors such as staurosporine and selumetinib disrupt kinase activities that are central to numerous signaling pathways, thereby potentially altering the phosphorylation state and activity of proteins such as MGC14376. Compounds like wortmannin and 5-Azacytidine can change intracellular signaling and gene expression patterns, respectively, which may adjust the cellular levels or activity of a protein like MGC14376 if it is involved in those pathways.
Histone deacetylase inhibitors like Trichostatin A trigger chromatin remodeling and can thus shift gene expression profiles, influencing the synthesis of a wide range of proteins. Chloroquine and thapsigargin interfere with cellular organelle function, namely lysosomes and the endoplasmic reticulum, which could affect proteins associated with these structures or reliant on their functions. The array of these inhibitors reflects the diverse biological processes that can be modulated to indirectly influence a protein's activity. They act through mechanisms such as altering the post-translational modification of proteins, changing the stability and folding of proteins, modulating gene expression, and affecting the trafficking and localization of proteins.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A non-selective protein kinase inhibitor, can alter phosphorylation states and affect protein function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor, can affect various signaling pathways, potentially impacting MGC14376 expression or activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor, can change chromatin structure and gene expression, impacting MGC14376 levels. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, can alter DNA methylation and gene expression, possibly affecting MGC14376. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $28.00 $80.00 $412.00 $1860.00 $2962.00 | 5 | |
A MEK inhibitor, can affect the MAPK/ERK pathway, potentially altering the activity of MGC14376. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor, can affect cytoskeleton organization, potentially influencing MGC14376 if related to cell structure. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
A Hsp90 inhibitor, can disrupt protein folding and stability, which may affect MGC14376. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
An SERCA pump inhibitor, can disrupt calcium homeostasis, potentially affecting MGC14376 if calcium-signaling related. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, potentially impacting MGC14376 if it is glycoprotein. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $46.00 $140.00 $680.00 | 16 | |
A FGFR inhibitor, could affect growth factor signaling pathways influencing MGC14376. | ||||||